Niagara falls and Orchard Park construction has finished and we have been operating in the new offices for sometime. 6933 Williams Road is the new address for our Niagara falls location. The following links will take you to Google maps and Google earth. Once there you can a first hand look at the area surrounding the building as well full view maps and aerial views.
Niagara Falls : 6933 Williams Road.
Orchard Park: 3345 Southwestern Boulevard
Our new Niagara Falls location is almost complete. Construction is wrapping up and we will soon be moving in. The new location is just across the street from our current location. You cannot miss it.
The new address is 6933 Williams Road.
We are hoping to completely up and running in December of 2015. 6000 additional sq feet is also available for anyone looking for new space. Contact Jerry Maciejewski @ 716-632-1595 for additional information.
Posted: Monday, August 17, 2015 3:00 am
By Mia Summerson mia.summerson@niagara-gazette.com
Construction has begun on a new 9,000 square foot medical office on the Williams Road side of the Summit Mall complex.
The new building will be occupied by Retina Consultants, a group of optometrists who specialize in the diagnosis and treatment of diseases of the retina and vitreous of the eye. The practice has offices at three Western New York locations, including one across the street from the new location in the Summit Healthplex.
“As a retina group, most of our patients are over the age of 65,” said Administrator Jerry Maciejewski. “They have difficulty seeing, or can’t see, and trying to find us in 100,000 square foot building with limited signage and their visual impairments makes it difficult. Let alone walking from the parking lot to the facility is a little far, it’s really a matter of convenience for patients.”
The building will be located near the main entrance to the mall off of Williams Road, near where the small M&T Bank branch used to be located. They firm purchased the property from new Summit Mall owner Zoran Cocov.
The new building while have space enough for both Retina Consultants and another business. They plan to rent the space out, ideally to another medical firm.
“We’re going to occupy 45,000 square feet of it and we’re looking for a tenant or tenants,” Maciejewski said. “Another medical group would obviously be nice, but any professional business. We don’t want a retail business.”
Another reason for the move, he said, is that the firm has outgrown its facility across the street. Patients often move through the process of exam, diagnosis and treatment quickly to save them time, money and to make things easier for the person driving them, as many of their clients are unable to drive themselves to and from appointments.
The new facility will add two more exam rooms and two more screening rooms. While they do not perform surgeries, the new facility will be equipped for some of the laser procedures done by the four doctors, who are Paul Lee, Mehdi Khan, Christopher Jermak and Ramakrishna Ratnakaram.
The new Retina Consultants is expected to open its doors sometime in October.
Article originally post in the Niagara gazette.
Dr. Faruk M. Koreishi, a nationally recognized eye surgeon with a practice in Niagara Falls, Williamsville and Orchard Park retired Friday August 1st 2015, after 40 years of service to the Western New York community.
The first physician in the Western New York area who restricted his practice to diseases and surgery of vitreous and retina – repair of damaged vitreous and retina in the back of the eye – Dr. Koreishi established the Retina Consultants of Western New York in 1975. Today the practice consists of four other retina specialists, who will be taking over the care of Dr. Koreishi’s patients.
Among his many accomplishments, he performed vision-saving surgery on former Buffalo Mayor Anthony Masiello in 1999. If left untreated, Masiello would have likely lost his vision. He has also treated professional boxers, artists, and coaches from Buffalo professional sports teams. Through his technical skills as a surgeon, Dr. Koreishi has helped thousands of people in Western New York maintain and improve their eyesight.
“When people get retina detachments and other retina diseases they lose vision. I’ve done surgery on patients and have brought their vision back,” he said, adding, “It is very gratifying to know that I’ve saved their vision. I’ve received so many cards thanking me. One wife wrote me a very touching letter that thanked me for saving her husband’s eye because they subsequently went to Hawaii where he could meet and see his family, as well as the beauty of Hawaii for a final time before an unexpected death.”
The news of his retirement spurred congratulatory letters of appreciation from both Congressmen Brian Higgens and Chris Collins. Mayor Byron Brown also declared July 31 as “Dr. Koreishi Day” in honor of his retirement.
Dr. Koreishi is a nationally renowned fellow of the American College of Surgeons. He is a member of the New York State Medical Society, the American Academy of Ophthalmology, and the Buffalo Ophthalmology Society. He has also served as the President of both the Asian Americans Physicians’ Association (AAPA), Erie County Medical Society and the WNY Ophthalmology Society. He is also an active member of the Islamic Society of Niagara Frontier, the Family Justice Center, and the Coalition for the Advancement of Muslim Women.
Over the years, Dr. Koreishi has been recognized on several occasions for his distinguished contributions to the healthcare industry. He received the 2014 Ross Eye Institute Community Ophthalmologist Of The Year Award, and in 2012, he was awarded Physician of the Year by the Asian American Physicians Association. He was also presented a human services award from the Muslim Public Affairs Council.
Dr. Koreishi resides in North Buffalo with his wife, Dr. Aziza Karimi, a Child Psychologist. They have been married for 46 years and have 4 children who are all doctors. They also have three grandchildren.
He plans to spend his retirement with his family, traveling, and enjoying his passion for photography and religion.
Article originally posted in the Niagara gazette.
We wish Dr Koreishi all the best. Our entire staff loves him and we will miss him dearly. He has had a profound effect on our lives, the lives of our families and most importantly the lives of his patients and the community.
May all your future endeavors produce the same results and more.
The entire staff of Retina Consultants of WNY
In February of this year Retina Consultants of WNY joined with Sisters Hospital at the St Joseph Campus in their newly renovated surgical suites.
Sisters of Charity Hospital St. Joseph Campus will now be home to some of the most sophisticated eye surgery in Western New York.
The physicians of Retina Consultants of Western New York have begun treating patients at the St. Joseph Campus in September of this year.
The Following video appeared on AM Buffalo with our Dr. Mehdi Khan.
http://www.wkbw.com/am-buffalo/retina-consultants-of-wny
On May 1st, 2014 – Faruk M. Koreishi, M.D. F.A.C.S responded to an article in the Buffalo News’ Opinion section. The article was printed on April 10, 2014 and was entitled,“Where the Medicare Millions Go”.
Dr. Koreishi’s response is as follows:
“We must reduce drug costs to curb Medicare spending.”
As a senior retina surgeon in practice for 38 years, I need to respond to the April 10 News article titled, “Where the Medicare millions go.” Ophthalmology has one of the highest percentages of elderly patients among medical specialties. Common and expensive ophthalmic diseases occur in this age group, including cataract, diabetic retinopathy, age-related macular degeneration (AMD), glaucoma, etc.
AMD is a leading cause of legal blindness in people over age 60 in the Western world. More than 3 million people experience visual loss due to AMD, a figure that may triple by the year 2020. For wet AMD, a more severe form, the treatment is the use of intravitreal injections. We are able to prevent legal blindness on a lot of these patients with very good results. The three commonly used drugs are Lucentis, Eylea and Avastin. The cost of either Lucentis or Eylea is approximately $2,000 per injection. Medicare pays 80 percent of the drug costs, which the doctor pays back to the drug company. The doctor does not make any money on these drugs. On the contrary, if the patient or the patient’s secondary insurance does not pay the doctor, a loss results.
Medicare reimbursement to the doctors can be very misleading. According to Dr. David W. Parke II, CEO of the American Academy of Ophthalmology, “Transparency is important, but drawing clinical conclusions from this particular data set is anything but transparent and easy.” The doctors should weigh the cost of the expensive drugs and their cost effectiveness versus the use of more reasonably priced drugs. The drug company can cut down the Medicare expense by lowering the cost of the expensive drug.
Faruk M. Koreishi, M.D., F.A.C.S.
After nearly four decades of caring for the eyesight of Western New Yorkers, Faruk M. Koreishi, MD, FACS, has been recognized as the Ross Eye Institute Community Ophthalmologist of the Year. The award, in recognition of Dr. Koreishi’s leadership and community service, was given at the Vision Beyond Sight Foundation’s First Annual “Eye Ball” this spring.
Since establishing a Buffalo-area practice in 1975, Dr. Koreishi shared his skill as a surgeon not only with thousands of patients, but also with hundreds of medical students as a faculty member at the State University of New York at Buffalo. He is currently in practice with the Retina Consultants of Western New York.
Reason for being recognized:
Dr. Faruk Koreishi, who established a Buffalo practice in 1975, was recognized as the Ross Eye Institute Community Ophthalmologist of the Year at the Vision Beyond Sight Foundation’s First Annual “Eye Ball” this spring. He’s currently in practice with the Retina Consultants of Western New York, with offices in Orchard Park, Williamsville, Niagara Falls and Ellicottville.
More about the Award:
http://www.buffalostories.com/koreishi.htm
All Eyes Are on Long Time WNY Surgeon as “Ophthalmologist of the Year” Dr. Faruk Koreishi has spent 40 years giving back…
By Steve Cichon steve@buffalostories.com | @stevebuffalo March 26, 2014
BUFFALO, NY – After nearly four decades of caring for the eyesight of Western New Yorkers, Dr. Faruk Koreishi has been recognized as the Ross Eye Institute Community Ophthalmologist of the Year. The award, in recognition of Dr. Koreishi’s leadership and community service, was given at the Vision Beyond Sight Foundation’s First Annual “Eye Ball” this spring.
The award’s sponsor, The Ross Eye Institute, provides diagnostic, treatment, and surgical services while serving as a research center for diseases of the eye and providing education to medical personnel in Western New York.
Since establishing a Buffalo area practice in 1975, Dr. Koreishi (right) shared his skill as a surgeon not only with thousands of patients, but also with hundreds of medical students as a faculty member at The State University of New York at Buffalo.
His personal and professional contributions to the greater good extend beyond his practice and beyond Western New York. Hospice, Meals on Wheels, Doctors Without Borders and many other charities count Dr. Koreishi as a friend. Professionally, Dr. Koreishi has served as President of the Asian American Physicians Association as well as the Western New York Ophthalmology Association.
Dr. Faruk Koreishi is currently in practice with The Retina Consultants of Western New York, with offices in Williamsville, Orchard Park, Niagara Falls, and Ellicottville.
More about The Vision Beyond Sight Foundation:
http://www.orgsites.com/ny/vbsf/
More about The Ross Eye Institute:
http://rosseye.com/
On August 20th 2013, our IT person Bob Souliske, released a new novel entitled “Ancient Darkness” in conjunction with Tate Publishing LLC.
Ancient darkness is a fantasy novel in the traditions of the classics like Lord of the Rings and the Chronicles of Narnia. However, it does not emulate or simply copy these classics, instead it tips its hat to them and attempts to forge forward.
The story takes place during a time of a “religious war”. An empire has risen that fanatically follows a religion of their own making. They have waged war upon all that refuse to follow. This “holy war” has consumed the world of Shadora, and in doing so has awaken and ancient and malevolent evil.
The main groups of characters are in the wrong places at the wrong time. They are thrown into the heart of the war as defenders of the truth “Light of creation”. They will defy and empire and resist an ancient darkness.
Jim Miller, marketing representative from Tate had this to say in a recent newspaper article concerning the novel.
Tate Publishing and Enterprises, LLC found the book had a major quality that it searched for in its products: marketability.
“Even though it’s a book in a popular genre, we felt it tells a different story,” said Jim Miller, a Tate marketing representative. Tate is a Christian-owned company and he said while the books published are not religious, per se, Souliske’s work “has a definite Christian resonance.”
Miller said the book is “well written, has good dialogue, and is very descriptive” in creating a “new world of sci-fi and fantasy.”
Creating such a new world is difficult, Miller explained, because many fantasy authors tend to copy classic works like The Lord of the Rings or the Chronicles of Narnia.
“We were looking for something that would have the ability to stand on its own, and we felt enough of the population will enjoy this book,” Miller added.
You can read the entire article here:
http://lockportjournal.com/local/x86510178/Local-authors-work-going-national
The book is available anywhere books are sold, but can be purchased online at amazon.com, barnes and noble online, or directly from the publisher at tatepublishing.com.
For more details and excerpts you can visit http://rksouliske.wordpress.com
Retina Consultants of Western New York strives to educate and treat our patients with precision, confidence and dedication. With these three ideals in mind we actively participate in clinical studies that we feel further the care of our patients. The following, lists our active clinical studies, as well as upcoming studies.
Active Studies:
1. Sponsor:
Diabetic Retinopathy Clinical Research Network (DRCR)
Principal Investigator:
Dr. Paul Lee
Clinical Trial Title:
Protocol N
An Evaluation of Intravitreal Ranibizumab (Lucentis) for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy
Synopsis:
To evaluate intravitreal ranibizumab (Lucentis) as treatment for vitreous hemorrhage from proliferative diabetic retinopathy in order to avoid vitrectomy.
NOT CURRENTLY ENROLLING
2. Sponsor:
Regeneron Pharmaceuticals Inc.
Principal Investigator:
Dr. Paul Lee
Clinical Trial Title:
VGFT-OD-1009
A Double-Masked, Randomized, Active-Controlled, Phase 3 Study of the Efficacy and Safety of Intravitreal Administration of VEGF Trap-Eye in Patients with Diabetic Macular Edema
Synopsis:
To assess the efficacy and safety of intravitreal (IVT) administration of vascular endothelial growth factor (VEGF) Trap-Eye compared to laser treatment in improving best corrected visual acuity (BCVA) in patients with diabetic macular edema (DME).
NOT CURRENTLY ENROLLING
3. Sponsor:
Regeneron Pharmaceuticals Inc.
Principal Investigator:
Dr. Mehdi Khan
Clinical Trial Title:
VGFTe-RVO-1027
A Double-Masked, Randomized, Active-Controlled Study of the Efficacy, Safety, and Tolerability of Intravitreal Administration of VEGF Trap-Eye (Intravitreal Aflibercept Injection [IAI]) in Patients with Macular Edema Secondary to Branch Retinal Vein Occlusion
Synopsis:
To assess the efficacy and safety of intravitreal (IVT) administration of vascular endothelial growth factor (VEGF) Trap-Eye in improving best corrected visual acuity (BCVA), compared to laser treatment, in patients with macular edema secondary to branch retinal vein occlusion (BRVO).
4. Sponsor:
Principal Investigator:
Dr. Ramakrishna Ratnakaram
Clinical Trial Title:
Santen 32-007
A Phase III, Multinational, Multicenter, Randomized, Double-Masked, Study Assessing the Safety and Efficacy of Intravitreal Injections of DE-109 (three doses) for the Treatment of active, Non-Infectious Uveitis of the Posterior Segment of the eye
Synopsis:
To evaluate the safety and efficacy of intravitreal injections of DE-109 (44ug, 440ug, 880ug) for the treatment of active, non-infectious uveitis of the posterior segment of the eye.
(November 2010)
Retina Consultants of Western New York, P.C. physician partners Faruk M. Koreishi, M.D., Paul J. Lee, M.D., Mehdi A. Khan, D.O., Christopher M. Jermak, M.D. are pleased to announce the addition of Ramakrishna (Ram) Ratnakaram, O.D., M.D. to our staff.
Dr. Ratnakaram was a tenured Associate Professor of Ophthalmology at the University of Florida College of Medicine, Gainesville, Florida until joining our practice. There he served as Director of Vitreo-Retinal Surgery & Fellowship training and as Medical Director of the eye clinics. During his time at the University, he published many papers and posters. He was the principle investigator in multiple clinical trials and is the lead surgeon in the NIH gene therapy research project
Dr. Ratnakaram obtained his first professional degree, Doctor of Optometry, from the University of Houston College of Optometry. Later he received his medical degree from Ross University School of Medicine. He completed his residency in Ophthalmology at UMDNJ-New Jersey Medical Scholl and received the Alfonse Cinnotti Award for Clinical Excellence. He later attended Tulane University College of Medicine for fellowship training in Vitreo-Retinal Surgery, diabetic retinopathy, age-related macular degeneration, retinopathy of prematurity, retinal laser procedures and other retinal diseases and treatments. Dr. Ratnakaram is board certified in Ophthalmology.
Dr. Ratnakaram is seeing patients at all three of our locations (Williamsville, Orchard Park and Niagara Falls). Please call (716) 795-2040 to schedule an appointment.
